iShares Biotechnology ETF
608 hedge funds and large institutions have $5.68B invested in iShares Biotechnology ETF in 2018 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 204 increasing their positions, 227 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% less first-time investments, than exits
New positions opened: 66 | Existing positions closed: 77
17% less funds holding in top 10
Funds holding in top 10: 30 → 25 (-5)
43% less call options, than puts
Call options by funds: $377M | Put options by funds: $657M
Holders
608
Holding in Top 10
25
Calls
$377M
Puts
$657M
Top Buyers
| 1 | +$447M | |
| 2 | +$106M | |
| 3 | +$43.4M | |
| 4 |
JG
Jefferies Group
New York
|
+$36.9M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$28.6M |
Top Sellers
| 1 | -$192M | |
| 2 | -$125M | |
| 3 | -$66.8M | |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$45.9M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$42.1M |